With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...
Pneumococcal disease poses a severe risk to Indian adults, particularly those with chronic health issues. Despite effective ...
While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 4 study titled ‘A Phase 4 Study Using a ...
The Healthy @Reader's Digest on MSN
I Just Got the Pneumonia Vaccine, and I’m Only in my 30s—Here’s Why I Made the Decision
Eligibility for this vaccination is suddenly a timely question. A senior health editor reports on her real-time experience.
The 19th News on MSN
The childhood vaccine schedule: What is it and why do we need one?
A series of recommended shots that health providers administer to children as they age has been a recent target of President ...
Merck & Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 3 STRIDE-13 trial evaluating CAPVAXIVE® (Pneumococcal 21-valent Conjugate ...
Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...
Warrington Guardian on MSN
Residents urged to take up flu and Covid-19 vaccine as winter weather sets in
RESIDENTS are being urged to take up the flu and Covid-19 vaccine as the winter weather sets in. The council says getting ...
The shingles vaccine may cut dementia risk by up to 33%, per new research. Here, experts explain how it works and what it may mean for brain health.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback